APO Research
Talk to an analyst

APO RESEARCH · REPORT

Malaria Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Malaria Drugs Market Outlook and Growth Opportunities 2026

21 December 2025192 pages

Choose your research edition.

Industry ResearchMalaria Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Malaria Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Malaria Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Malaria Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Malaria Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Malaria Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Malaria Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Malaria Drugs market include Ajanta Pharma, Cipla, Guilin Pharmaceutical, IPCA Laboratories, Sanofi Aventis, GlaxoSmithKline, Kunming Pharmaceutical, Roche and Mylan Labs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Malaria Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Malaria Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Malaria Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Malaria Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Malaria Drugs Segment by Company

Ajanta Pharma

Cipla

Guilin Pharmaceutical

IPCA Laboratories

Sanofi Aventis

GlaxoSmithKline

Kunming Pharmaceutical

Roche

Mylan Labs

Novartis

Malaria Drugs Segment by Type

Artemisinin Compounds

Antifolate Compounds

Aryl Aminoalcohol Compounds

Malaria Drugs Segment by Application

Prevention

Treatment

Other

Malaria Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Malaria Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Malaria Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Malaria Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Malaria Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Malaria Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Malaria Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Malaria Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Malaria Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Malaria Drugs industry.

Chapter 3: Detailed analysis of Malaria Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Malaria Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Malaria Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Malaria Drugs Industry Trends Table 2. Malaria Drugs Industry Drivers Table 3. Malaria Drugs Industry Opportunities and Challenges Table 4. Malaria Drugs Industry Restraints Table 5. Global Malaria Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Malaria Drugs Revenue Share by Company (2021-2026) Table 7. Global Malaria Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Malaria Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Malaria Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Malaria Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Malaria Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Malaria Drugs Company, Product Type & Application Table 13. Global Malaria Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Malaria Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Artemisinin Compounds Table 18. Significant Companies of Antifolate Compounds Table 19. Significant Companies of Aryl Aminoalcohol Compounds Table 20. Global Malaria Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Malaria Drugs Sales Volume by Type (2021-2026) & (k units) Table 22. Global Malaria Drugs Sales Volume by Type (2027-2032) & (k units) Table 23. Global Malaria Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Malaria Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Malaria Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Malaria Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Malaria Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Malaria Drugs Sales Value Share by Type (2021-2026) Table 29. Global Malaria Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Prevention Table 31. Significant Companies of Treatment Table 32. Significant Companies of Other Table 33. Global Malaria Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Malaria Drugs Sales Volume by Application (2021-2026) & (k units) Table 35. Global Malaria Drugs Sales Volume by Application (2027-2032) & (k units) Table 36. Global Malaria Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Malaria Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Malaria Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Malaria Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Malaria Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Malaria Drugs Sales Value Share by Application (2021-2026) Table 42. Global Malaria Drugs Sales Value Share by Application (2027-2032) Table 43. Global Malaria Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Malaria Drugs Sales by Region (2021-2026) & (k units) Table 45. Global Malaria Drugs Sales Market Share by Region (2021-2026) Table 46. Global Malaria Drugs Sales by Region (2027-2032) & (k units) Table 47. Global Malaria Drugs Sales Market Share by Region (2027-2032) Table 48. Global Malaria Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Malaria Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Malaria Drugs Sales Value Share by Region (2021-2026) Table 51. Global Malaria Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Malaria Drugs Sales Value Share by Region (2027-2032) Table 53. Global Malaria Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Malaria Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Malaria Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Malaria Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Malaria Drugs Sales by Country (2021-2026) & (k units) Table 58. Global Malaria Drugs Sales Market Share by Country (2021-2026) Table 59. Global Malaria Drugs Sales by Country (2027-2032) & (k units) Table 60. Global Malaria Drugs Sales Market Share by Country (2027-2032) Table 61. Global Malaria Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Malaria Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Malaria Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Malaria Drugs Sales Value Market Share by Country (2027-2032) Table 65. Ajanta Pharma Company Information Table 66. Ajanta Pharma Business Overview Table 67. Ajanta Pharma Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Ajanta Pharma Malaria Drugs Product Portfolio Table 69. Ajanta Pharma Recent Development Table 70. Cipla Company Information Table 71. Cipla Business Overview Table 72. Cipla Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Cipla Malaria Drugs Product Portfolio Table 74. Cipla Recent Development Table 75. Guilin Pharmaceutical Company Information Table 76. Guilin Pharmaceutical Business Overview Table 77. Guilin Pharmaceutical Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Guilin Pharmaceutical Malaria Drugs Product Portfolio Table 79. Guilin Pharmaceutical Recent Development Table 80. IPCA Laboratories Company Information Table 81. IPCA Laboratories Business Overview Table 82. IPCA Laboratories Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. IPCA Laboratories Malaria Drugs Product Portfolio Table 84. IPCA Laboratories Recent Development Table 85. Sanofi Aventis Company Information Table 86. Sanofi Aventis Business Overview Table 87. Sanofi Aventis Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Sanofi Aventis Malaria Drugs Product Portfolio Table 89. Sanofi Aventis Recent Development Table 90. GlaxoSmithKline Company Information Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. GlaxoSmithKline Malaria Drugs Product Portfolio Table 94. GlaxoSmithKline Recent Development Table 95. Kunming Pharmaceutical Company Information Table 96. Kunming Pharmaceutical Business Overview Table 97. Kunming Pharmaceutical Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Kunming Pharmaceutical Malaria Drugs Product Portfolio Table 99. Kunming Pharmaceutical Recent Development Table 100. Roche Company Information Table 101. Roche Business Overview Table 102. Roche Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Roche Malaria Drugs Product Portfolio Table 104. Roche Recent Development Table 105. Mylan Labs Company Information Table 106. Mylan Labs Business Overview Table 107. Mylan Labs Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Mylan Labs Malaria Drugs Product Portfolio Table 109. Mylan Labs Recent Development Table 110. Novartis Company Information Table 111. Novartis Business Overview Table 112. Novartis Malaria Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Novartis Malaria Drugs Product Portfolio Table 114. Novartis Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Malaria Drugs Distributors List Table 118. Malaria Drugs Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Malaria Drugs Product Image Figure 2. Global Malaria Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Malaria Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Malaria Drugs Sales (2021-2032) & (k units) Figure 5. Global Malaria Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Malaria Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Artemisinin Compounds Image Figure 10. Antifolate Compounds Image Figure 11. Aryl Aminoalcohol Compounds Image Figure 12. Global Malaria Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Malaria Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Malaria Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Malaria Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Malaria Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Malaria Drugs Sales Value Share by Type (2021-2032) Figure 18. Prevention Image Figure 19. Treatment Image Figure 20. Other Image Figure 21. Global Malaria Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Malaria Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Malaria Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Malaria Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Malaria Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Malaria Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Malaria Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Malaria Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Malaria Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Malaria Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Malaria Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Malaria Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Malaria Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Malaria Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Malaria Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Malaria Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Malaria Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Malaria Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Malaria Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Malaria Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Malaria Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Malaria Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Malaria Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Malaria Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Malaria Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Artemisinin Compounds
  • Antifolate Compounds
  • Aryl Aminoalcohol Compounds
Applications
  • Prevention
  • Treatment
  • Other
Companies covered
  • Ajanta Pharma
  • Cipla
  • Guilin Pharmaceutical
  • IPCA Laboratories
  • Sanofi Aventis
  • GlaxoSmithKline
  • Kunming Pharmaceutical
  • Roche
  • Mylan Labs
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Malaria Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Malaria Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Malaria Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Malaria Drugs Market Dynamics
  1. 2.1 Malaria Drugs Industry Trends
  2. 2.2 Malaria Drugs Industry Drivers
  3. 2.3 Malaria Drugs Industry Opportunities and Challenges
  4. 2.4 Malaria Drugs Industry Restraints
3 Malaria Drugs Market by Company
  1. 3.1 Global Malaria Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Malaria Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Malaria Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Malaria Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Malaria Drugs Company Ranking (2024-2026)
  6. 3.6 Global Malaria Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Malaria Drugs Company Product Type and Application
  8. 3.8 Global Malaria Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Malaria Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Malaria Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Malaria Drugs Market by Type
  1. 4.1 Malaria Drugs Type Introduction
  2. 4.1.1 Artemisinin Compounds
  3. 4.1.2 Antifolate Compounds
  4. 4.1.3 Aryl Aminoalcohol Compounds
  5. 4.2 Global Malaria Drugs Sales Volume by Type
  6. 4.2.1 Global Malaria Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Malaria Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Malaria Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Malaria Drugs Sales Value by Type
  10. 4.3.1 Global Malaria Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Malaria Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Malaria Drugs Sales Value Share by Type (2021-2032)
5 Malaria Drugs Market by Application
  1. 5.1 Malaria Drugs Application Introduction
  2. 5.1.1 Prevention
  3. 5.1.2 Treatment
  4. 5.1.3 Other
  5. 5.2 Global Malaria Drugs Sales Volume by Application
  6. 5.2.1 Global Malaria Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Malaria Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Malaria Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Malaria Drugs Sales Value by Application
  10. 5.3.1 Global Malaria Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Malaria Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Malaria Drugs Sales Value Share by Application (2021-2032)
6 Malaria Drugs Regional Sales and Value Analysis
  1. 6.1 Global Malaria Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Malaria Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Malaria Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Malaria Drugs Sales by Region (2027-2032)
  5. 6.3 Global Malaria Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Malaria Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Malaria Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Malaria Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Malaria Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Malaria Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Malaria Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Malaria Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Malaria Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Malaria Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Malaria Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Malaria Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Malaria Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Malaria Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Malaria Drugs Sales Value Share by Country, 2025 VS 2032
7 Malaria Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Malaria Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Malaria Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Malaria Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Malaria Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Malaria Drugs Sales by Country (2027-2032)
  6. 7.4 Global Malaria Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Malaria Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Malaria Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Malaria Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Malaria Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Malaria Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Malaria Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Malaria Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Malaria Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Malaria Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Malaria Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Malaria Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Malaria Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Malaria Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Malaria Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Malaria Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Malaria Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Malaria Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Malaria Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Malaria Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Malaria Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Malaria Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Malaria Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Malaria Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Malaria Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Malaria Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Malaria Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Malaria Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Malaria Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Malaria Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Malaria Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Malaria Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Malaria Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Malaria Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajanta Pharma
  2. 8.1.1 Ajanta Pharma Company Information
  3. 8.1.2 Ajanta Pharma Business Overview
  4. 8.1.3 Ajanta Pharma Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ajanta Pharma Malaria Drugs Product Portfolio
  6. 8.1.5 Ajanta Pharma Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Malaria Drugs Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Guilin Pharmaceutical
  14. 8.3.1 Guilin Pharmaceutical Company Information
  15. 8.3.2 Guilin Pharmaceutical Business Overview
  16. 8.3.3 Guilin Pharmaceutical Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Guilin Pharmaceutical Malaria Drugs Product Portfolio
  18. 8.3.5 Guilin Pharmaceutical Recent Developments
  19. 8.4 IPCA Laboratories
  20. 8.4.1 IPCA Laboratories Company Information
  21. 8.4.2 IPCA Laboratories Business Overview
  22. 8.4.3 IPCA Laboratories Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 IPCA Laboratories Malaria Drugs Product Portfolio
  24. 8.4.5 IPCA Laboratories Recent Developments
  25. 8.5 Sanofi Aventis
  26. 8.5.1 Sanofi Aventis Company Information
  27. 8.5.2 Sanofi Aventis Business Overview
  28. 8.5.3 Sanofi Aventis Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Aventis Malaria Drugs Product Portfolio
  30. 8.5.5 Sanofi Aventis Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Malaria Drugs Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Kunming Pharmaceutical
  38. 8.7.1 Kunming Pharmaceutical Company Information
  39. 8.7.2 Kunming Pharmaceutical Business Overview
  40. 8.7.3 Kunming Pharmaceutical Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kunming Pharmaceutical Malaria Drugs Product Portfolio
  42. 8.7.5 Kunming Pharmaceutical Recent Developments
  43. 8.8 Roche
  44. 8.8.1 Roche Company Information
  45. 8.8.2 Roche Business Overview
  46. 8.8.3 Roche Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Roche Malaria Drugs Product Portfolio
  48. 8.8.5 Roche Recent Developments
  49. 8.9 Mylan Labs
  50. 8.9.1 Mylan Labs Company Information
  51. 8.9.2 Mylan Labs Business Overview
  52. 8.9.3 Mylan Labs Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Labs Malaria Drugs Product Portfolio
  54. 8.9.5 Mylan Labs Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Malaria Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Malaria Drugs Product Portfolio
  60. 8.10.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Malaria Drugs Value Chain Analysis
  2. 9.1.1 Malaria Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Malaria Drugs Sales Mode & Process
  6. 9.2 Malaria Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Malaria Drugs Distributors
  9. 9.2.3 Malaria Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst